Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
PL-001 by Pell Bio-Med Technology for Primary Mediastinal B-Cell Lymphoma: Likelihood of Approval
PL-001 is under clinical development by Pell Bio-Med Technology and currently in Phase II for Primary Mediastinal B-Cell Lymphoma. According...
PL-001 by Pell Bio-Med Technology for Diffuse Large B-Cell Lymphoma: Likelihood of Approval
PL-001 is under clinical development by Pell Bio-Med Technology and currently in Phase II for Diffuse Large B-Cell Lymphoma. According...
PL-001 by Pell Bio-Med Technology for Follicular Lymphoma: Likelihood of Approval
PL-001 is under clinical development by Pell Bio-Med Technology and currently in Phase II for Follicular Lymphoma. According to GlobalData,...